News
Enhance FDA compliance with our expanded training on inspection processes, common issues, and strategies for prevention. Gain insights into Form 483 and warning letter prevention, root cause analysis, ...
Fleetworthy has announced the official launch of Expedited Inspection, a feature available exclusively through Drivewyze by ...
New feature for trucks passing through Nevada saves fleets time and money by automating HOS transfers and reducing delays and ...
Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San Diego manufacturing facility for Deramiocel, the company’s lead ...
The inspection concluded with a Form 483 containing several observations. The Company has submitted its responses to the FDA, none of which required material changes to the cGMP process or facility.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results